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Protein quantification expressing their differential expression is 
underpinning the efforts to identify potential biomarkers.  The fact, that there 
could be hundreds of proteins in a signaling pathway or forming a particular 
protein class of interest (such as kinases), puts strains on development of 
targeted assays using immunoassays. The utilization of SRM assays on 
proteotypic peptides used as ‘surrogates’ for proteins of interest provides an 
equally effective approach for protein quantitation.  
The selection of a suitable proteotypic peptide is, however, far from 
straightforward. So far, in silico predictions remain inferior to the empirical 
peptide strategy. In addition to the obvious concerns regarding adequate 
selectivity and sensitivity, issues arise with respect to ‘real protein’ 
characteristics, such as modifications, folding, digestion efficiency. Using a 
recombinant protein of interest would resolve most of the above mentioned 
issues.  
The Thermo Scientific Pierce Human In Vitro Protein Expression 
System (IVT) is a method for expressing proteins from DNA or mRNA 
templates in a cell-free solution containing essential components of the 
cellular translational machinery. Extracts of an immortalized human cell line 
provide the ribosomes, initiation and elongation factors, tRNAs and other 
basic components required for protein synthesis. When supplemented with 
proprietary accessory proteins, ATP, and an energy regenerating system, 
such an IVT can produce proteins for use in the mass spectrometry assays 
in two and a half hours. Human proteins expressed using Heavy IVT system 
show higher than 90% heavy isotope incorporation. Moreover, proteins are 
produced appropriately folded and modified, as tested for expressed 
phosphorylated or glycosylated proteins. 
In vitro protein expression system combined with SRM represents a 
scalable strategy for targeted peptide selection. It will be discussed in more 
detail for a subset of transcription factors representing various signal 
transduction pathways. 
 
